Estrogenic ovulatory dysfunction or functional female hyperandrogenism: an argument to discard the term polycystic ovary syndrome

Ontogeny of the ovary in polycystic ovary syndrome

Rosiglitazone treatment alleviates inflammation and improves liver function in overweight women with polycystic ovary syndrome: a randomized placebo-controlled study

The importance of insulin resistance in polycystic ovary syndrome

Long-term consequences of polycystic ovary syndrome on cardiovascular risk

Not all women diagnosed with PCOS share the same cardiovascular risk profiles

Increased monocyte chemoattractant protein-1 levels indicating early vascular damage in lean young PCOS patients

Metformin in the treatment of infertility in polycystic ovarian syndrome: an alternative perspective

Lower serum apelin levels in women with polycystic ovary syndrome

A variant in the fibrillin-3 gene is associated with TGF-β and inhibin B levels in women with polycystic ovary syndrome

Metformin treatment does not affect total leptin levels and free leptin index in obese patients with polycystic ovary syndrome

Female overweight is not associated with a higher embryo euploidy rate in first trimester miscarriages karyotyped by hysteroembryoscopy

Anti-Müllerian hormone (AMH) defines, independent of age, low versus good live-birth chances in women with severely diminished ovarian reserve

In vitro maturation of oocytes: uncommon indications

The effect of modifying dietary protein and carbohydrate in weight loss on arterial compliance and postprandial lipidemia in overweight women with polycystic ovary syndrome

Abnormal aminotransferase activity in women with polycystic ovary syndrome